cephalothin has been researched along with amoxicillin in 85 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 9 (10.59) | 18.7374 |
1990's | 7 (8.24) | 18.2507 |
2000's | 49 (57.65) | 29.6817 |
2010's | 19 (22.35) | 24.3611 |
2020's | 1 (1.18) | 2.80 |
Authors | Studies |
---|---|
Bambury, RE; Baumann, RJ; Böhme, EH; Erickson, RC; Harrison, BL; Hoffman, PF; McCarty, FJ; Schnettler, RA; Vaal, MJ; Wenstrup, DL | 1 |
Branland, P; Granet, R; Kaldapa, C; Krausz, P; Sol, V; Verneuil, B | 1 |
Apiwattanakul, N; Endou, H; Jariyawat, S; Kanai, Y; Sekine, T; Sophasan, S; Takeda, M | 1 |
Brandsch, M; Luckner, P | 1 |
Cattoir, V; Nordmann, P; Poirel, L; Soares, A; Soussy, CJ | 1 |
Bonnet, R; Chanal, C; Delmas, J; Lesens, O; Robin, F; Schweitzer, C; Tournilhac, O | 1 |
Aubert, D; Naas, T; Nordmann, P; Ozcan, A | 1 |
Arlet, G; Loli, A; Miriagou, V; Papagiannitsis, CC; Tzelepi, E; Tzouvelekis, LS | 1 |
Caniça, M; Ferreira, E; Leitão, J; Manageiro, V; Mendonça, N | 1 |
Cattoir, V; Corvec, S; Drugeon, H; Faccone, D; Galas, M; Mugnier, P; Nordmann, P; Pasteran, F; Petroni, A; Poirel, L; Rapoport, M | 1 |
Kwon, DH; Lu, CD | 1 |
Bille, J; Lartigue, MF; Nordmann, P; Poirel, L; Wenger, A; Zinsius, C | 1 |
Miriagou, V; Papagiannitsis, CC; Tzelepi, E; Tzouvelekis, LS | 1 |
Bonnet, R; Brebion, A; Constantin, JM; Delmas, J; Dubois, D; Robin, F | 1 |
Girlich, D; Leclercq, R; Naas, T; Nordmann, P | 1 |
Calvet, L; Devine, R; Dubreuil, L; Jean-Pierre, H; Jumas-Bilak, E; Marchandin, H; Mercier, G; Morio, F | 1 |
Bonnet, R; Neuwirth, C; Robin, F; Siebor, E | 1 |
Cuzon, G; Demachy, MC; Naas, T; Nordmann, P | 1 |
Courvalin, P; Decré, D; Høiby, EA; Meziane-Cherif, D; Périchon, B | 1 |
Courvalin, P; Dupêchez, M; Galimand, M; Lambert, T; Meziane-Cherif, D | 1 |
Cuzon, G; Lartigue, MF; Naas, T; Nordmann, P; Quinn, JP; Villegas, MV | 1 |
Bonnet, R; Caniça, M; Ferreira, E; Manageiro, V; Mendonça, N; Robin, F; Salgado, MJ | 1 |
Bonnet, R; Caniça, M; Manageiro, V; Mendonça, N | 1 |
Doi, Y; Nordmann, P; Paterson, DL; Poirel, L | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Jarlier, V; Mayer, C; Petrella, S; Renard, M; Sougakoff, W; Ziental-Gelus, N | 1 |
Cattoir, V; Nordmann, P; Poirel, L | 1 |
Corvaglia, AR; Demarta, A; Nordmann, P; Petrini, O; Picão, RC; Poirel, L | 1 |
Bogaerts, P; Cuzon, G; Glupczynski, Y; Huang, TD; Naas, T; Nordmann, P | 1 |
Arpin, C; Bezian, MC; Coulange, L; Demarthe, F; Dubois, V; Minarini, LA; Nordmann, P; Poirel, L; Quentin, C | 1 |
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
Arakawa, Y; Ishikawa, K; Nagano, N; Nagano, Y; Wachino, J | 1 |
Bonnet, R; Delmas, J; Pradel, N; Santini, CL; Wu, LF | 1 |
Galleni, M; Mammeri, H; Nordmann, P | 1 |
Nordmann, P; Plésiat, P; Poirel, L; Rodriguez-Martinez, JM | 1 |
Kotsakis, SD; Miriagou, V; Tzelepi, E; Tzouvelekis, LS; Whichard, JM; Zioga, A | 1 |
Nordmann, P; Poirel, L; Rodríguez-Martínez, JM | 1 |
Bonnet, R; Brisabois, A; Cloeckaert, A; Doublet, B; Fabre, L; Granier, SA; Robin, F; Weill, FX | 1 |
Chanteperdrix, V; Croizé, J; Nordmann, P; Poirel, L; Potron, A | 1 |
Kotsakis, SD; Miriagou, V; Papagiannitsis, CC; Tzelepi, E; Tzouvelekis, LS | 1 |
Ghori, S; Griggs, DJ; Johnson, MM; Mott, A; Peake, L; Piddock, LJ | 1 |
De Luca, F; Delmarcelle, M; Docquier, JD; Dubus, A; Frère, JM; Nacoulma, OG; Rossolini, GM; Simporé, J; Zeba, B | 1 |
Distèche-Nguyen, M; Gerards, T; Luxen, A; Miguet, L; Pasha, FA; Thomas, A; Zervosen, A | 1 |
Higgins, PG; Lehmann, M; Nordmann, P; Poirel, L; Seifert, H | 1 |
Girlich, D; Nordmann, P; Poirel, L | 3 |
Bonnet, R; Casin, I; Doublet, B; Fabre, L; Le Fleche, A; Robin, F; Weill, FX | 1 |
De Luca, F; Docquier, JD; Ide, L; Nordmann, P; Poirel, L; Rossolini, GM; Verlinde, A | 1 |
Aggoune-Khinache, N; Bonnet, R; Delmas, J; Naim, M; Robin, F | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Kotsakis, SD; Legakis, NJ; Miriagou, V; Papagiannitsis, CC; Tzelepi, E; Tzouvelekis, LS | 1 |
Akan, OA; Carrër, A; Cuzon, G; Feriha, C; Honderlick, P; Matar, G; Nordmann, P; Poirel, L; Yilmaz, M | 1 |
De Luca, F; Docquier, JD; Fosse, T; Giraud-Morin, C; Rossolini, GM | 1 |
Albuquerque, L; Bonnet, R; Caniça, M; Ferreira, E; Manageiro, V | 1 |
Eb, F; Guillon, H; Mammeri, H | 1 |
Al Naiemi, N; Debets-Ossenkopp, YJ; Nordmann, P; Poirel, L; Rodríguez-Martínez, JM | 1 |
Nordmann, P; Poirel, L; Rodríguez-Martínez, JM; Ronco, E | 1 |
Caspers, P; Danel, F; Glushkov, AI; Kellenberger, L; Page, MG; Pohlmann, J; Shapiro, S; Vasilevich, NI | 1 |
Kotsakis, SD; Miriagou, V; Tzelepi, E; Tzouvelekis, LS | 1 |
Gozalbes, R; Pineda-Lucena, A | 1 |
Aldini, G; De Luca, L; Marconi, C; Pedretti, A; Regazzoni, L; Vistoli, G | 1 |
Anderson, KC; Kellogg, GE; Sarkar, A | 1 |
Kosakai, N; Oguri, T | 1 |
Emerson, BB; Harding, AL; Smith, AL; Smith, DH | 1 |
Wilkinson, PM | 1 |
Murray, BE; Pickering, LK; Reves, RR; Singh, KV | 1 |
Duval, J; Le Van Thoi, J; Soussy, CJ | 1 |
Chanal, M; Cluzel, M; Cluzel, R; Joly, B; Saulnier, P; Sirot, D; Sirot, J | 1 |
Johnson, WK; Nash, DR; Steele, LC; Steingrube, VA; Wallace, RJ | 1 |
Sirinavin, S; Suthas-Na-Ayuthaya, P | 1 |
Cynamon, MH; Palmer, GS | 1 |
Bordon, F; Gutmann, L; Kitzis, MD; Sirot, D; Zhou, XY | 1 |
Carret, G; Flandrois, JP; Guerillot, F | 1 |
Chanal, C; Dabernat, H; Huc, C; Labia, R; Lemozy, J; Sirot, D; Sirot, J | 1 |
el Bekkouri, A; Gutiérez Navarro, P; Rodríguez Reinoso, E | 1 |
Domínguez, L; Fernández-Garayzábal, JF; Latre, MV; Moreno, MA; Rodríguez, AA; Vela, AI | 1 |
Bertrand, X; Lallemand-De-Conto, S; Talon, D; Thouverez, M | 1 |
Alonso, E; Froeling, F; Hak, E; Hoepelman, IM; Matute, AJ; McArthur, A; Paniagua, M; Roskott, AM; Rozenberg-Arska, M; Schurink, CA; Van Asbeck, E | 1 |
Ben Meriem, C; Ghedira Besbes, L; Guediche, MN; Messaoudi, A | 1 |
Carroll, S; Goonetilleke, A; Hargreaves, M | 1 |
Bingen, E | 1 |
Brohede, U; Engqvist, H; Forsgren, J; Mihranyan, A; Roos, S; Strømme, M | 1 |
Alperi, A; Figueras, MJ; Gonzalo, N; Ko, WC; Martínez-Murcia, AJ; Navarro, M; Saavedra, MJ | 1 |
Abbasi, SA; Ali, S; Andleeb, S; Awan, UA; Imdad, K; Mughal, TA; Nasreen, S; Raja, SA | 1 |
85 other study(ies) available for cephalothin and amoxicillin
Article | Year |
---|---|
Orally active cephalosporins and penicillins.
Topics: Administration, Oral; Animals; Bacterial Infections; Cephalosporins; Injections, Subcutaneous; Male; Mice; Microbial Sensitivity Tests; Penicillins; Structure-Activity Relationship | 1980 |
Nitroglycosylated meso-arylporphyrins as photoinhibitors of gram positive bacteria.
Topics: Anti-Bacterial Agents; Escherichia coli; Glycosylation; Photochemotherapy; Porphyrins; Staphylococcus aureus | 1998 |
The interaction and transport of beta-lactam antibiotics with the cloned rat renal organic anion transporter 1.
Topics: Animals; Anion Transport Proteins; Anti-Bacterial Agents; Biological Transport; Carrier Proteins; Cell Survival; Cephaloridine; Cephalosporins; In Vitro Techniques; Kidney; Kinetics; Oocytes; p-Aminohippuric Acid; Penicillin G; Rats; Recombinant Proteins; Xenopus laevis | 1999 |
Interaction of 31 beta-lactam antibiotics with the H+/peptide symporter PEPT2: analysis of affinity constants and comparison with PEPT1.
Topics: Animals; Anti-Bacterial Agents; beta-Lactams; Binding Sites; Caco-2 Cells; Dose-Response Relationship, Drug; Humans; Peptide Transporter 1; Protein Binding; Rats; Symporters | 2005 |
Novel Ambler class A beta-lactamase LAP-1 and its association with the plasmid-mediated quinolone resistance determinant QnrS1.
Topics: Amino Acid Sequence; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Cloning, Molecular; Enterobacter cloacae; Gene Expression Regulation, Bacterial; Gene Expression Regulation, Enzymologic; Molecular Sequence Data; Plasmids; Quinolones; Sequence Alignment | 2007 |
Evolution of TEM-type enzymes: biochemical and genetic characterization of two new complex mutant TEM enzymes, TEM-151 and TEM-152, from a single patient.
Topics: beta-Lactamases; Drug Resistance, Bacterial; Escherichia coli; Evolution, Molecular; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Mutation | 2007 |
Chromosome-encoded narrow-spectrum Ambler class A beta-lactamase GIL-1 from Citrobacter gillenii.
Topics: beta-Lactamases; Chromosomes; Chromosomes, Bacterial; Citrobacter; Cloning, Molecular; DNA, Bacterial; Escherichia coli; Gene Expression Regulation, Bacterial; Gene Expression Regulation, Enzymologic; Genes, Bacterial; Molecular Sequence Data | 2007 |
SCO-1, a novel plasmid-mediated class A beta-lactamase with carbenicillinase characteristics from Escherichia coli.
Topics: Amino Acid Sequence; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Escherichia coli; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Penicillinase; Plasmids; Sequence Analysis, DNA | 2007 |
Spread of extended-spectrum beta-lactamase CTX-M-producing escherichia coli clinical isolates in community and nosocomial environments in Portugal.
Topics: Aged; Anti-Bacterial Agents; beta-Lactamases; Community-Acquired Infections; Cross Infection; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Humans; Microbial Sensitivity Tests; Middle Aged; Portugal | 2007 |
Identification of the novel narrow-spectrum beta-lactamase SCO-1 in Acinetobacter spp. from Argentina.
Topics: Acinetobacter; Acinetobacter Infections; Amino Acid Sequence; Anti-Bacterial Agents; Argentina; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Clavulanic Acid; Cloning, Molecular; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Sequence Analysis, DNA | 2007 |
Polyamine effects on antibiotic susceptibility in bacteria.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactams; Drug Resistance, Bacterial; Drug Synergism; Gram-Negative Bacteria; Humans; Microbial Sensitivity Tests; Polyamines; Spermine; Staphylococcus aureus | 2007 |
Extended-spectrum beta-lactamases of the CTX-M type now in Switzerland.
Topics: Anti-Bacterial Agents; beta-Lactamases; Community-Acquired Infections; Enterobacteriaceae; Enterobacteriaceae Infections; Escherichia coli; Hospitals, University; Humans; Microbial Sensitivity Tests; Molecular Epidemiology; Polymerase Chain Reaction; Prevalence; Switzerland | 2007 |
Plasmid-encoded ACC-4, an extended-spectrum cephalosporinase variant from Escherichia coli.
Topics: Anti-Bacterial Agents; Cephalosporinase; Culture Media; DNA Primers; Drug Resistance, Bacterial; Escherichia coli; Kinetics; Models, Molecular; Molecular Sequence Data; Plasmids; Reverse Transcriptase Polymerase Chain Reaction; Spectrophotometry, Ultraviolet | 2007 |
TEM-158 (CMT-9), a new member of the CMT-type extended-spectrum beta-lactamases.
Topics: beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Catalysis; Ceftazidime; Clavulanic Acid; Escherichia coli; Escherichia coli Proteins; Isoenzymes; Kinetics; Microbial Sensitivity Tests; Molecular Sequence Data; Sequence Analysis, DNA | 2007 |
Molecular and biochemical characterization of the chromosome-encoded class A beta-lactamase BCL-1 from Bacillus clausii.
Topics: Amino Acid Sequence; Bacillus; Bacterial Proteins; beta-Lactamases; Chromosome Mapping; Chromosomes, Bacterial; Cloning, Molecular; Microbial Sensitivity Tests; Molecular Sequence Data; Molecular Weight; Sequence Homology, Amino Acid; Substrate Specificity | 2007 |
Antimicrobial susceptibilities and clinical sources of Dialister species.
Topics: Anti-Bacterial Agents; Drug Resistance, Bacterial; Gram-Negative Bacterial Infections; Humans; Microbial Sensitivity Tests; Species Specificity; Veillonellaceae | 2007 |
First occurrence of an IMP metallo-beta-lactamase in Aeromonas caviae: IMP-19 in an isolate from France.
Topics: Aeromonas; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; France; Integrons; Kinetics; Microbial Sensitivity Tests; Molecular Sequence Data; Plasmids; Sequence Analysis, DNA; Substrate Specificity | 2007 |
Plasmid-mediated carbapenem-hydrolyzing beta-lactamase KPC-2 in Klebsiella pneumoniae isolate from Greece.
Topics: Adult; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Carbapenems; Female; Greece; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Plasmids | 2008 |
Genetic and biochemical characterization of CAD-1, a chromosomally encoded new class A penicillinase from Carnobacterium divergens.
Topics: Amino Acid Sequence; beta-Lactams; Chromosomes, Bacterial; Cloning, Molecular; Electrophoresis, Gel, Pulsed-Field; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Infant, Newborn; Kinetics; Microbial Sensitivity Tests; Molecular Sequence Data; Penicillin Resistance; Penicillinase; Sequence Alignment; Sequence Analysis, DNA; Substrate Specificity | 2008 |
Genetic and biochemical characterization of OXA-63, a new class D beta-lactamase from Brachyspira pilosicoli BM4442.
Topics: Amino Acid Sequence; Anti-Bacterial Agents; Base Sequence; beta-Lactamases; Brachyspira; Cloning, Molecular; Diarrhea; Feces; Gram-Negative Bacterial Infections; Humans; Kinetics; Molecular Sequence Data; Oxacillin; Penicillin Resistance; Sequence Analysis, DNA | 2008 |
Genetic structures at the origin of acquisition of the beta-lactamase bla KPC gene.
Topics: Base Sequence; beta-Lactamases; beta-Lactams; Cloning, Molecular; Colombia; DNA Transposable Elements; Greece; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Molecular Sequence Data; Pseudomonas aeruginosa; Pseudomonas Infections; Sequence Analysis, DNA; United States | 2008 |
The Lys234Arg substitution in the enzyme SHV-72 is a determinant for resistance to clavulanic acid inhibition.
Topics: Amino Acid Substitution; Amoxicillin; Anti-Bacterial Agents; Arginine; Aztreonam; Bacterial Proteins; beta-Lactamase Inhibitors; beta-Lactamases; Cephalosporins; Clavulanic Acid; Computer Simulation; Imipenem; Isoelectric Focusing; Kinetics; Klebsiella pneumoniae; Lysine; Microbial Sensitivity Tests; Models, Molecular; Molecular Sequence Data; Penicillins; Protein Conformation; Protein Structure, Tertiary | 2008 |
Biochemical characterization of SHV-55, an extended-spectrum class A beta-lactamase from Klebsiella pneumoniae.
Topics: Anti-Bacterial Agents; beta-Lactamases; Kinetics; Klebsiella pneumoniae | 2008 |
Characterization of a naturally occurring class D beta-lactamase from Achromobacter xylosoxidans.
Topics: Achromobacter denitrificans; Amino Acid Sequence; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Cloning, Molecular; Humans; Kinetics; Microbial Sensitivity Tests; Molecular Sequence Data; Sequence Analysis, DNA | 2008 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Genetic and structural insights into the dissemination potential of the extremely broad-spectrum class A beta-lactamase KPC-2 identified in an Escherichia coli strain and an Enterobacter cloacae strain isolated from the same patient in France.
Topics: Aged; Base Sequence; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Catalytic Domain; Cephalosporin Resistance; Crystallography, X-Ray; DNA Primers; DNA, Bacterial; Enterobacter cloacae; Enterobacteriaceae Infections; Escherichia coli; Escherichia coli Infections; France; Genes, Bacterial; Humans; Imipenem; Kinetics; Male; Models, Molecular; Mutation | 2008 |
Plasmid-mediated quinolone resistance pump QepA2 in an Escherichia coli isolate from France.
Topics: Aged; Base Sequence; DNA Primers; DNA, Bacterial; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Female; Fluoroquinolones; France; Genes, Bacterial; Humans; Models, Genetic; Molecular Sequence Data; Plasmids | 2008 |
Expanded-spectrum beta-lactamase PER-1 in an environmental Aeromonas media isolate from Switzerland.
Topics: Aeromonas; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Fresh Water; Microbial Sensitivity Tests; Polymerase Chain Reaction; Rivers; Sewage; Switzerland | 2008 |
Plasmid-encoded carbapenem-hydrolyzing beta-lactamase OXA-48 in an imipenem-susceptible Klebsiella pneumoniae strain from Belgium.
Topics: Adult; Anti-Bacterial Agents; Belgium; beta-Lactamases; beta-Lactams; Carbapenems; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Plasmids | 2008 |
Molecular and biochemical characterization of SHV-56, a novel inhibitor-resistant beta-lactamase from Klebsiella pneumoniae.
Topics: Aged; Amino Acid Substitution; Base Sequence; beta-Lactam Resistance; beta-Lactamases; DNA Primers; DNA, Bacterial; Female; Genes, Bacterial; Humans; Isoelectric Point; Kinetics; Klebsiella Infections; Klebsiella pneumoniae; Molecular Sequence Data; Mutagenesis, Insertional; Recombinant Proteins | 2008 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Novel chimeric beta-lactamase CTX-M-64, a hybrid of CTX-M-15-like and CTX-M-14 beta-lactamases, found in a Shigella sonnei strain resistant to various oxyimino-cephalosporins, including ceftazidime.
Topics: Amino Acid Sequence; beta-Lactamases; Blotting, Southern; Ceftazidime; Cephalosporins; Kinetics; Microbial Sensitivity Tests; Molecular Sequence Data; Polymerase Chain Reaction; Sequence Homology, Amino Acid; Shigella sonnei | 2009 |
Sec- and Tat-dependent translocation of beta-lactamases across the Escherichia coli inner membrane.
Topics: Amoxicillin; beta-Lactamases; Cefotaxime; Ceftazidime; Cephalothin; Escherichia coli; Escherichia coli Proteins; Green Fluorescent Proteins; Microbial Sensitivity Tests; Piperacillin; Protein Transport | 2009 |
Role of the Ser-287-Asn replacement in the hydrolysis spectrum extension of AmpC beta-lactamases in Escherichia coli.
Topics: Asparagine; Bacterial Proteins; beta-Lactamases; Cephalosporins; Escherichia coli; Escherichia coli Proteins; Hydrolysis; Microbial Sensitivity Tests; Models, Molecular; Mutagenesis, Site-Directed; Protein Structure, Secondary; Serine | 2009 |
Naturally occurring Class A ss-lactamases from the Burkholderia cepacia complex.
Topics: Alleles; Amino Acid Sequence; Amino Acid Substitution; Base Sequence; beta-Lactamases; Burkholderia cepacia complex; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Humans; Hydrolysis; Isoelectric Point; Kinetics; Microbial Sensitivity Tests; Molecular Sequence Data; Phylogeny; Plasmids; Sequence Analysis, DNA; Sequence Homology, Amino Acid | 2009 |
CMY-31 and CMY-36 cephalosporinases encoded by ColE1-like plasmids.
Topics: Alleles; Amino Acid Sequence; Amino Acid Substitution; Arginine; Base Sequence; beta-Lactamase Inhibitors; beta-Lactamases; Cephalosporinase; Citrobacter freundii; Cysteine; DNA Transposable Elements; DNA, Bacterial; Escherichia coli; Genes, Bacterial; Glutamine; Humans; Hydrolysis; Inhibitory Concentration 50; Isoelectric Point; Kinetics; Klebsiella pneumoniae; Microbial Sensitivity Tests; Models, Genetic; Models, Molecular; Molecular Sequence Data; Plasmids; Salmonella enterica; Sequence Analysis, DNA; Species Specificity; Substrate Specificity; Transformation, Genetic | 2009 |
Extended-spectrum cephalosporinases in Pseudomonas aeruginosa.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Ceftazidime; Cephalosporinase; Humans; Imipenem; Microbial Sensitivity Tests; Molecular Sequence Data; Pseudomonas aeruginosa; Sequence Analysis, DNA | 2009 |
Novel plasmid-encoded ceftazidime-hydrolyzing CTX-M-53 extended-spectrum beta-lactamase from Salmonella enterica serotypes Westhampton and Senftenberg.
Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Cardiidae; Ceftazidime; Ceftriaxone; Cephalosporin Resistance; Electrophoresis, Gel, Pulsed-Field; France; Microbial Sensitivity Tests; Plasmids; Polymerase Chain Reaction; Salmonella enterica; Serotyping | 2009 |
Genetic and biochemical characterization of the first extended-spectrum CARB-type beta-lactamase, RTG-4, from Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Amino Acid Sequence; Anti-Bacterial Agents; beta-Lactamases; Drug Resistance, Bacterial; Escherichia coli; Kinetics; Microbial Sensitivity Tests; Molecular Sequence Data; Mutagenesis, Site-Directed | 2009 |
Extended-spectrum properties of CMY-30, a Val211Gly mutant of CMY-2 cephalosporinase.
Topics: Aztreonam; beta-Lactamases; beta-Lactams; Ceftazidime; Cephalosporins; Escherichia coli Proteins; Protein Binding; Protein Structure, Secondary | 2009 |
Beta-lactamase-mediated beta-lactam resistance in Campylobacter species: prevalence of Cj0299 (bla OXA-61) and evidence for a novel beta-Lactamase in C. jejuni.
Topics: Amino Acid Sequence; Amoxicillin; Ampicillin; Animals; Anti-Bacterial Agents; Base Sequence; beta-Lactam Resistance; beta-Lactamases; Blotting, Southern; Campylobacter jejuni; Carbenicillin; Cephalosporins; Chickens; Cloxacillin; Isoelectric Focusing; Mass Spectrometry; Microbial Sensitivity Tests; Molecular Sequence Data; Penicillins; Piperacillin; Polymerase Chain Reaction; Sequence Alignment; Ticarcillin | 2009 |
IND-6, a highly divergent IND-type metallo-beta-lactamase from Chryseobacterium indologenes strain 597 isolated in Burkina Faso.
Topics: Adult; Amino Acid Sequence; Anti-Bacterial Agents; beta-Lactamases; Cefepime; Ceftazidime; Cephalexin; Cephalosporins; Cephalothin; Chryseobacterium; Female; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Phylogeny; Protein Structure, Secondary; Sequence Homology, Amino Acid | 2009 |
Discovery of new inhibitors of resistant Streptococcus pneumoniae penicillin binding protein (PBP) 2x by structure-based virtual screening.
Topics: Computational Biology; Computer Simulation; Drug Discovery; Drug Evaluation, Preclinical; Drug Resistance, Bacterial; Ligands; Penicillin-Binding Proteins; Protein Binding; Streptococcus pneumoniae; Structure-Activity Relationship | 2009 |
OXA-143, a novel carbapenem-hydrolyzing class D beta-lactamase in Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Amino Acid Sequence; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Drug Resistance, Multiple, Bacterial; Escherichia coli; Imipenem; Meropenem; Molecular Sequence Data; Oxacillin; Penicillins; Polymerase Chain Reaction; Sequence Analysis, DNA; Sequence Homology, Amino Acid; Thienamycins | 2009 |
First isolation of the blaOXA-23 carbapenemase gene from an environmental Acinetobacter baumannii isolate.
Topics: Acinetobacter baumannii; beta-Lactamases; DNA, Bacterial; Escherichia coli; France; Genes, Bacterial; Water Microbiology | 2010 |
Molecular and biochemical characterization of the natural chromosome-encoded class A beta-lactamase from Pseudomonas luteola.
Topics: Amino Acid Sequence; Anti-Bacterial Agents; beta-Lactamases; Catheters, Indwelling; Chromosomes, Bacterial; Cloning, Molecular; Electrophoresis, Gel, Pulsed-Field; Genes, Bacterial; Genetic Variation; Isoelectric Focusing; Kinetics; Microbial Sensitivity Tests; Molecular Sequence Data; Phylogeny; Plasmids; Pseudomonas; Pseudomonas Infections; Recombinant Proteins; Reverse Transcriptase Polymerase Chain Reaction; Substrate Specificity | 2010 |
BEL-2, an extended-spectrum beta-lactamase with increased activity toward expanded-spectrum cephalosporins in Pseudomonas aeruginosa.
Topics: Belgium; beta-Lactamases; Cephalosporinase; Cephalosporins; Cross Infection; Escherichia coli; Genes, Bacterial; Humans; Kinetics; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections | 2010 |
Novel ambler class A carbapenem-hydrolyzing beta-lactamase from a Pseudomonas fluorescens isolate from the Seine River, Paris, France.
Topics: Amino Acid Sequence; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Blotting, Southern; Cloning, Molecular; DNA, Bacterial; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; France; Fresh Water; Gram-Negative Bacteria; Health Surveys; Kinetics; Microbial Sensitivity Tests; Molecular Sequence Data; Plasmids; Pseudomonas fluorescens; Water Microbiology | 2010 |
Novel VIM metallo-beta-lactamase variant from clinical isolates of Enterobacteriaceae from Algeria.
Topics: Algeria; Anti-Bacterial Agents; Base Sequence; beta-Lactamases; beta-Lactams; Carbapenems; DNA, Bacterial; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Genome, Bacterial; Hospitals, Military; Imipenem; Isoelectric Focusing; Kinetics; Microbial Sensitivity Tests; Molecular Sequence Data; Penicillins; Phenotype | 2010 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
GES-13, a beta-lactamase variant possessing Lys-104 and Asn-170 in Pseudomonas aeruginosa.
Topics: Anti-Bacterial Agents; Aztreonam; beta-Lactamases; beta-Lactams; Cephalosporins; Genetic Variation; Humans; Integrons; Microbial Sensitivity Tests; Molecular Sequence Data; Pseudomonas aeruginosa; Pseudomonas Infections; Sequence Analysis, DNA | 2010 |
Spread of OXA-48-encoding plasmid in Turkey and beyond.
Topics: Anti-Bacterial Agents; Belgium; beta-Lactam Resistance; beta-Lactamases; Carbapenems; DNA Transposable Elements; Egypt; Enterobacteriaceae; Enterobacteriaceae Infections; France; Humans; Lebanon; Microbial Sensitivity Tests; Plasmids; Turkey | 2010 |
Genetic and biochemical characterization of TRU-1, the endogenous class C beta-lactamase from Aeromonas enteropelogenes.
Topics: Aeromonas; Amino Acid Sequence; Base Sequence; beta-Lactamases; Cloning, Molecular; DNA Primers; DNA, Bacterial; Drug Resistance, Bacterial; Escherichia coli; Genes, Bacterial; Humans; Kinetics; Molecular Sequence Data; Phylogeny; Sequence Homology, Amino Acid; Sequence Homology, Nucleic Acid; Transformation, Genetic | 2010 |
PER-6, an extended-spectrum beta-lactamase from Aeromonas allosaccharophila.
Topics: Aeromonas; Animals; Base Sequence; beta-Lactamases; DNA Primers; DNA, Bacterial; Genes, Bacterial; Humans; Kinetics; Microbial Sensitivity Tests; Molecular Sequence Data; Paris; Water Microbiology | 2010 |
Biochemical study of a new inhibitor-resistant beta-lactamase, SHV-84, produced by a clinical Escherichia coli strain.
Topics: beta-Lactam Resistance; beta-Lactamases; Escherichia coli; Escherichia coli Proteins; Molecular Sequence Data | 2010 |
Characterization of CSP-1, a novel extended-spectrum beta-lactamase produced by a clinical isolate of Capnocytophaga sputigena.
Topics: Amino Acid Sequence; Amoxicillin; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Capnocytophaga; Cephalosporins; Gram-Negative Bacterial Infections; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Sepsis | 2010 |
Characterization of DIM-1, an integron-encoded metallo-beta-lactamase from a Pseudomonas stutzeri clinical isolate in the Netherlands.
Topics: Amino Acid Sequence; Bacterial Proteins; Base Sequence; beta-Lactamases; Cloning, Molecular; DNA, Bacterial; Drug Resistance, Bacterial; Genes, Bacterial; Humans; Integrons; Middle Aged; Molecular Sequence Data; Netherlands; Pseudomonas Infections; Pseudomonas stutzeri; Sequence Homology, Amino Acid; Substrate Specificity | 2010 |
Extended-spectrum cephalosporinase in Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Amino Acid Sequence; Amino Acid Substitution; Anti-Bacterial Agents; Aztreonam; Bacterial Proteins; beta-Lactamases; Cefepime; Ceftazidime; Cephalosporin Resistance; Cephalosporinase; Cephalosporins; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Monobactams; Mutagenesis, Site-Directed | 2010 |
Propenylamide and propenylsulfonamide cephalosporins as a novel class of anti-MRSA beta-lactams.
Topics: Amides; Anti-Bacterial Agents; beta-Lactams; Cephalosporins; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Structure-Activity Relationship | 2010 |
Comparative biochemical and computational study of the role of naturally occurring mutations at Ambler positions 104 and 170 in GES β-lactamases.
Topics: Ampicillin; beta-Lactamases; Computational Biology; Escherichia coli; Hydrogen Bonding; Microbial Sensitivity Tests; Mutagenesis, Site-Directed; Protein Structure, Secondary; Ticarcillin | 2010 |
QSAR-based solubility model for drug-like compounds.
Topics: Databases, Factual; Models, Molecular; Pharmaceutical Preparations; Quantitative Structure-Activity Relationship; Solubility; Water | 2010 |
Fragmental modeling of hPepT2 and analysis of its binding features by docking studies and pharmacophore mapping.
Topics: Binding Sites; Computer Simulation; Drug Design; Humans; Ligands; Models, Molecular; Peptides; Protein Binding; Structural Homology, Protein; Symporters | 2011 |
Computational analysis of structure-based interactions and ligand properties can predict efflux effects on antibiotics.
Topics: Anti-Bacterial Agents; beta-Lactams; Computational Biology; Drug Resistance, Bacterial; Hydrophobic and Hydrophilic Interactions; Ligands; Membrane Transport Proteins; Microbial Sensitivity Tests; Models, Molecular; Protein Binding; Protein Conformation; Quantitative Structure-Activity Relationship; Regression Analysis; Thermodynamics | 2012 |
[Distribution and changes of antibiotic susceptibility of genus Haemophilus (author's transl)].
Topics: Amoxicillin; Ampicillin; Anti-Bacterial Agents; Carbenicillin; Cefazolin; Cephalexin; Cephalothin; Chloramphenicol; Colistin; Cyclacillin; Dibekacin; Doxycycline; Gentamicins; Haemophilus; Kanamycin; Penicillin Resistance; Streptomycin; Sulbenicillin; Tetracyclines; Thiamphenicol | 1976 |
Hemophilus influenzae type B susceptibility to 17 antibiotics.
Topics: Amoxicillin; Ampicillin; Anti-Bacterial Agents; Cefazolin; Cephalexin; Cephaloridine; Cephalothin; Cephradine; Chloramphenicol; Clindamycin; Culture Media; Erythromycin; Gentamicins; Haemophilus influenzae; Kanamycin; Penicillin G; Penicillin Resistance; Rifampin; Tetracycline | 1975 |
Clinical pharmacology of antibiotic therapy.
Topics: Aminoglycosides; Amoxicillin; Ampicillin; Anti-Bacterial Agents; Carbenicillin; Cephalexin; Cephaloridine; Cephalothin; Chloramphenicol; Clindamycin; Cloxacillin; Creatinine; Drug Therapy, Combination; Erythromycin; Floxacillin; Gentamicins; Humans; Kidney Diseases; Lincomycin; Methicillin; Penicillin G; Penicillins; Tetracyclines | 1976 |
Comparative in vitro activities of amoxicillin-clavulanic acid, cefuroxime, cephalexin, and cephalothin against trimethoprim-resistant Escherichia coli isolated from stools of children attending day-care centers.
Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Cefuroxime; Cephalexin; Cephalothin; Child Day Care Centers; Child, Preschool; Clavulanic Acids; Drug Therapy, Combination; Escherichia coli; Feces; Humans; Infant; Microbial Sensitivity Tests; Plasmids; Trimethoprim Resistance | 1990 |
[Sensitivity to clavulanic acid of Escherichia coli isolated at the Henri Mondor hospital in 1986 according to phenotypes of beta-lactam antibiotic resistance].
Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Carbenicillin; Cefotaxime; Cephalothin; Clavulanic Acid; Clavulanic Acids; Drug Combinations; Drug Resistance, Microbial; Escherichia coli; Microbial Sensitivity Tests; Penicillin Resistance; Phenotype | 1988 |
Resistance to beta-lactams in Enterobacteriaceae: distribution of phenotypes related to beta-lactamase production.
Topics: Amoxicillin; Anti-Bacterial Agents; beta-Lactamases; Cephalothin; Clavulanic Acid; Clavulanic Acids; Enterobacteriaceae; Penicillin Resistance; Phenotype; Ticarcillin | 1986 |
Beta-lactam resistance in Nocardia brasiliensis is mediated by beta-lactamase and reversed in the presence of clavulanic acid.
Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Ampicillin Resistance; Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactamases; Cefamandole; Cefotaxime; Ceftriaxone; Cephalothin; Clavulanic Acids; Drug Combinations; Humans; Isoelectric Focusing; Microbial Sensitivity Tests; Nocardia; Penicillin Resistance; Ticarcillin | 1987 |
Diphtheritic septicaemia and probable endocarditis: a case report and review of the literature.
Topics: Amoxicillin; Ampicillin; Cephalothin; Child; Diphtheria; Drug Combinations; Drug Therapy, Combination; Endocarditis, Bacterial; Female; Gentamicins; Humans; Sepsis; Sulfamethoxazole; Surgical Wound Infection; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination | 1985 |
In vitro susceptibility of Mycobacterium fortuitum to amoxicillin or cephalothin in combination with clavulanic acid.
Topics: Amoxicillin; beta-Lactamases; Cephalothin; Clavulanic Acids; Drug Combinations; Microbial Sensitivity Tests; Mycobacterium; Nontuberculous Mycobacteria | 1983 |
Emergence of clinical isolates of Escherichia coli producing TEM-1 derivatives or an OXA-1 beta-lactamase conferring resistance to beta-lactamase inhibitors.
Topics: Amoxicillin; Base Sequence; beta-Lactamase Inhibitors; beta-Lactamases; Cephalothin; Clavulanic Acid; Clavulanic Acids; Escherichia coli; Escherichia coli Infections; Humans; Kinetics; Microbial Sensitivity Tests; Molecular Sequence Data; Point Mutation; Polymerase Chain Reaction | 1994 |
Mathematical model for comparison of time-killing curves.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Cell Cycle; Cephalothin; Escherichia coli; Kinetics; Mathematical Computing; Microbial Sensitivity Tests; Models, Biological; Nalidixic Acid; Ofloxacin; Pefloxacin; Time Factors | 1993 |
First characterization of inhibitor-resistant TEM (IRT) beta-lactamases in Klebsiella pneumoniae strains.
Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactamases; Cephalosporins; Cephalothin; Clavulanic Acids; DNA, Bacterial; Drug Resistance, Microbial; Drug Therapy, Combination; Electrophoresis, Polyacrylamide Gel; Enzyme Inhibitors; Escherichia coli; Isoelectric Focusing; Klebsiella pneumoniae; Microbial Sensitivity Tests; Polymerase Chain Reaction | 1995 |
Spectrofluorimetric study of the degradation of alpha-amino beta-lactam antibiotics catalysed by metal ions in methanol.
Topics: Amoxicillin; Ampicillin; Anti-Bacterial Agents; Cadmium; Catalysis; Cations, Divalent; Cephalothin; Cobalt; Metals; Methanol; Spectrometry, Fluorescence; Zinc | 1998 |
Antimicrobial susceptibility of Listeria monocytogenes isolated from meningoencephalitis in sheep.
Topics: Amoxicillin; Animal Feed; Animals; Anti-Bacterial Agents; Brain; Cephalosporins; Cephalothin; Chloramphenicol; Ciprofloxacin; Doxycycline; Drug Resistance, Microbial; Erythromycin; Gentamicins; Kanamycin; Listeria monocytogenes; Listeriosis; Meningoencephalitis; Microbial Sensitivity Tests; Penicillin G; Penicillins; Rifampin; Sheep; Sheep Diseases; Sulfisoxazole; Tetracycline; Trimethoprim; Vancomycin | 2001 |
[E. coli: resistance to quinolones and beta-lactams of clinical strains isolated in the Franche-Comté region of France].
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactams; Ceftazidime; Cephalothin; Ciprofloxacin; Clavulanic Acid; Community-Acquired Infections; Cross Infection; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Drug Utilization; Escherichia coli; Escherichia coli Infections; Female; Fluoroquinolones; France; Genotype; Humans; Male; Middle Aged; Nalidixic Acid; Phenotype; Selection, Genetic; Urinary Tract Infections | 2004 |
Resistance of uropathogens in symptomatic urinary tract infections in León, Nicaragua.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Bacteria; Cephalothin; Drug Combinations; Drug Resistance, Bacterial; Enterobacter; Escherichia coli; Female; Humans; Klebsiella; Male; Microbial Sensitivity Tests; Nicaragua; Pyuria; Quinolones; Risk Factors; Sulfamethizole; Trimethoprim; Urinary Bladder Diseases; Urinary Incontinence; Urinary Tract Infections; Urine | 2004 |
[Profile of antimicrobial resistance of agents causing urinary tract infections in children].
Topics: Adolescent; Age Factors; Aminoglycosides; Amoxicillin; Ampicillin; Ampicillin Resistance; Anti-Bacterial Agents; Anti-Infective Agents, Urinary; Bacteria; Cephalosporin Resistance; Cephalosporins; Cephalothin; Child; Child, Preschool; Clavulanic Acid; Drug Resistance, Bacterial; Enterobacteriaceae Infections; Escherichia coli; Female; Humans; Infant; Klebsiella pneumoniae; Male; Penicillin Resistance; Proteus mirabilis; Retrospective Studies; Sex Factors; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections | 2004 |
Sourcing faecal pollution from onsite wastewater treatment systems in surface waters using antibiotic resistance analysis.
Topics: Amoxicillin; Animals; Anti-Bacterial Agents; Cephalothin; Chlortetracycline; Colony Count, Microbial; Discriminant Analysis; Drug Resistance, Bacterial; Erythromycin; Escherichia coli; Feces; Gentamicins; Humans; Moxalactam; Ofloxacin; Tetracycline; Water Microbiology; Water Pollution | 2005 |
[Antibiotic resistance of bacterial strains in paediatric infections: there are resistance and resistance!].
Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Ampicillin Resistance; Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Bacteria; beta-Lactamases; Cephalosporin Resistance; Cephalothin; Child; Ciprofloxacin; Clindamycin; Dose-Response Relationship, Drug; Drug Resistance, Bacterial; Drug Synergism; Enzyme Inhibitors; Escherichia coli; Humans; Microbial Sensitivity Tests; Nalidixic Acid; Nucleic Acid Synthesis Inhibitors; Shigella sonnei; Staphylococcus aureus | 2008 |
Multifunctional implant coatings providing possibilities for fast antibiotics loading with subsequent slow release.
Topics: Agar; Amoxicillin; Anti-Bacterial Agents; Biomimetics; Cephalothin; Coated Materials, Biocompatible; Drug Delivery Systems; Durapatite; Gentamicins; Humans; Microbial Sensitivity Tests; Staphylococcus aureus; Time Factors; Titanium; Tobramycin | 2009 |
Clinical relevance of the recently described species Aeromonas aquariorum.
Topics: Aeromonas; Amoxicillin; Anti-Bacterial Agents; Bacterial Proteins; Bacterial Typing Techniques; Blood; Cefoxitin; Cephalothin; DNA, Bacterial; Drug Resistance, Bacterial; Feces; Genotype; Gram-Negative Bacterial Infections; Humans; Microbial Sensitivity Tests; Phylogeny; Polymorphism, Restriction Fragment Length; RNA, Bacterial; RNA, Ribosomal, 16S; Virulence Factors | 2009 |
Screening of Antibacterial Efficacy of Chitosan Encapsulated Probiotics (Lactococcus lactis and Lactobacillus curvattus) against Clinical Bacterial Pathogens.
Topics: Amoxicillin; Animals; Anti-Bacterial Agents; Buffaloes; Ceftriaxone; Cephalothin; Cephradine; Chitosan; Chloramphenicol; Ciprofloxacin; Erythromycin; Lactobacillus; Lactococcus lactis; Probiotics; Tetracyclines; Tobramycin | 2022 |